Loading...
Buy ORLY now. The stock is sitting just above a key pivot/support area (97.67) in pre-market (98.49) with improving (but not overextended) momentum, strong Q3 2025 growth, and a clearly supportive Wall Street stance (multiple Outperform ratings with targets well above the current price). Despite mixed near-term options volume (heavy put volume) and an earnings event on 2026-02-04, the balance of evidence favors upside from current levels for an impatient buyer rather than waiting for a “perfect” entry.
Trend/Setup: Mild bullish-to-neutral. Price is holding above the Pivot 97.667, suggesting support is nearby; upside levels are R1 101.248 then R2 103.46, while downside risk levels are S1 94.085 then S2 91.873. Momentum: MACD histogram is positive (0.749) but contracting, implying bullish momentum is present but cooling (not a strong breakout signal). RSI(6)=56 is neutral—room to move without being overbought. Moving averages: Converging MAs typically indicate consolidation; combined with price near pivot, this favors a directional move soon, with near-term risk defined by the 97.67/94.09 support band.
Intellectia Proprietary Trading Signals

Hedge funds are buying aggressively (buying amount up ~150% over the last quarter), supporting institutional demand.
Analyst backdrop is strongly positive (multiple Outperform ratings and new coverage initiation).
Core business is delivering steady growth and margin stability (Q3 2025 results: revenue, EPS, and net income all up YoY).
Price is near a well-defined technical pivot (97.667), offering a nearby reference level for support.
Options flow shows heavy put volume today (put-call volume ratio 3.47), signaling short-term caution and potential near-term drawdown risk.
Pattern-based forecast provided suggests a negative bias over the next month (-4.53%), implying near-term volatility/consolidation risk.
Upcoming earnings on 2026-02-04 after hours can drive a sharp move either direction (event risk).
No company-specific positive news catalysts were provided; the listed news appears macro/geopolitical and not directly supportive for ORLY.
Latest quarter (2025/Q3): Revenue $4.706B (+7.82% YoY), Net Income $725.9M (+9.08% YoY), EPS $0.85 (+11.84% YoY). Gross margin improved to 51.85% (+0.52 YoY). Overall: consistent growth with modest margin expansion—fundamentally supportive for buying dips/near support.
Recent Street trend is positive: Baird initiated with Outperform and a $115 target (calling ORLY a “value creation machine”), Raymond James upgraded to Outperform with a $105 target after a clean Q3 and pullback, and Evercore maintained Outperform while trimming target slightly to $110. Wall Street pros: consistent execution/ROIC narrative, pricing tailwinds, comp visibility, potential EBIT margin inflection. Wall Street cons (implied from target trim/pullback context): valuation sensitivity and expectations risk into upcoming earnings; short-term sentiment can wobble (seen in put-heavy volume). Politician/congress trading: no recent congress trading data available; no notable politician activity provided.